Hot Investor Mandate 3: Cross-Border VC Fund Invests Opportunistically in USA and China Life Science Technologies

23 Nov

A leading investment and advisory firm with USA and China offices is currently interested in investing in privately held companies in the TMT (Tech, Media, and Telecom) and healthcare sector. The firm currently manages two funds, a $150M VC fund which only invests in China, and a $50M early-stage fund that focuses on investments into US start-ups. The firm is planning to raise a second and much larger US fund in next 12 months. On average, the initial size of investment is in the $2-3M range. The firm is looking for attractive investment opportunities in North America and China.

The firm is a flexible and opportunistic investor that is currently considering therapeutics, medical devices, diagnostics, genomics, healthcare services and healthcare IT companies. With respect to medical devices, the firm is interested in devices with all FDA regulatory pathways, including 510k, PMA, and software-enabled devices.

The firm prefers to act as the lead investor but is also open to co-investing. The firm will neither seek a board seat nor seek distribution rights.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: